These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 7527840

  • 1. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity.
    Xu X, Li GD, Kong YY, Yang HL, Zhang Z, Cao HT, Wang Y.
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3673-7. PubMed ID: 7527840
    [Abstract] [Full Text] [Related]

  • 2. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
    Prange R, Werr M, Birkner M, Hilfrich R, Streeck RE.
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY, Ryu CJ, Gripon P, Guguen-Guillouzo C, Hong HJ.
    Virology; 2000 Apr 25; 270(1):9-16. PubMed ID: 10772975
    [Abstract] [Full Text] [Related]

  • 5. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM, Sominskaya I, Skrastina D, Pumpens P, El Wahed AA, Beutling U, Frank R, Fritz HJ, Hunsmann G, Gerlich WH, Glebe D.
    J Hepatol; 2011 Jul 25; 55(1):29-37. PubMed ID: 21145866
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X.
    J Virol Methods; 2007 Apr 25; 141(1):41-8. PubMed ID: 17197041
    [Abstract] [Full Text] [Related]

  • 8. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H, Deng Y, Tan W, Wang W, Yin X, Guan J, Wang W, Ruan L.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan 25; 26(1):74-8. PubMed ID: 20353095
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L.
    Acta Virol; 1996 Jan 25; 40(5-6):273-9. PubMed ID: 9171455
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT, Boo I, Drummer HE, Netter HJ.
    Antivir Ther; 2007 Jan 25; 12(4):477-87. PubMed ID: 17668556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Stable and efficient expression of hepatitis B virus S antigen and preS1 epitope fusion protein (S/preS1) in CHO cells].
    Yang Z, Li S, Liu H, Zhang M, Ye L, Wu Y, Xu M, Chen Z.
    Sheng Wu Gong Cheng Xue Bao; 2013 Dec 25; 29(12):1808-16. PubMed ID: 24660628
    [Abstract] [Full Text] [Related]

  • 15. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
    Theilmann L, Goeser T.
    Hepatogastroenterology; 1991 Feb 25; 38(1):10-3. PubMed ID: 1709133
    [Abstract] [Full Text] [Related]

  • 16. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
    Borisova G, Borschukova O, Skrastina D, Dislers A, Ose V, Pumpens P, Grens E.
    Biol Chem; 1999 Mar 25; 380(3):315-24. PubMed ID: 10223334
    [Abstract] [Full Text] [Related]

  • 17. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Dobrica MO, Lazar C, Paruch L, van Eerde A, Clarke JL, Tucureanu C, Caras I, Ciulean S, Onu A, Tofan V, Branzan A, Urban S, Stavaru C, Branza-Nichita N.
    Vaccine; 2018 Sep 11; 36(38):5789-5795. PubMed ID: 30082163
    [Abstract] [Full Text] [Related]

  • 18. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F, Peterson D, Hughes J, Wirtz R, Milich D.
    J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391
    [Abstract] [Full Text] [Related]

  • 19. [A recombinant vaccinia virus expressing the middle preS2-S envelope protein of the hepatitis B virus. The induction of humoral and cellular immunity by the immunization of laboratory animals].
    Beliaev AS, Dmitriev IP, Ignat'ev GM, Mizenko GA, Putintseva NI, Sabirov AN, Samukov VV, Semënova LN, Ammosov AD, Rukavishnikov MIu.
    Dokl Akad Nauk SSSR; 1990 Jan 26; 314(2):488-91. PubMed ID: 2265587
    [No Abstract] [Full Text] [Related]

  • 20. Detection of cellular receptors specific for the hepatitis B virus preS surface protein on cell lines of extrahepatic origin.
    Park JH, Choi EA, Cho EW, Lee YJ, Park JM, Na SY, Kim KL.
    Biochem Biophys Res Commun; 2000 Oct 14; 277(1):246-54. PubMed ID: 11027670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.